Estimation of Cortisone Acetate in Pharmaceutical Anti-inflammatory Drugs by HPLC-UV Technique
Journal: International Journal of Science and Research (IJSR) (Vol.6, No. 2)Publication Date: 2017-02-05
Authors : H. N. K. AL-Salman; Shaker.A.N.AL-Jadaan;
Page : 1178-1183
Keywords : Cortisone acetate; Oral Tablets; formulation; and HPLC- UV System;
Abstract
The HPLC-UV System was used to assay of Cortisone acetate in Oral Tablets So, compare the bioavailability of two types of Cortisone acetate, commercial formulations and Cortisone acetate analar grade as a test formulation. Cortisone acetate concentrations were analyzed by HPLC-UV System at (=254 nm). The separation was achieved by using the Ion Pac Ercus C18 RP-Column, 5m, 4.6250 mm. The mobile phase consisted of water /acetonitrile (5545). The study of bioequivalence between the two Cortisone acetate formulations were assessed by calculating peaks height. The standard Cortisone acetate eluted at a flow rate of 1.0 ml/min. The method was found to belinear in the range (0.5 to 2.5) g/ml (n = 5) with R2 0.9991, also, the recoveries were range within 99-100 %. The detection limit of quantification (LLOQ) was 0.07909g/ml and lower limit of detection (LLOD) 0.02610 g/ml. showing average intra assay and inter-assay coefficients of RSD % about 0.522 %. The results of recoveries, RSD, and statistical parameters obtained in this study. The accurate, precise and sensitive refers to validation method for determination of Cortisone acetate in anti-inflammatory Pharmaceutical drugs.
Other Latest Articles
- Composite Operators on Atomic Orlicz Spaces
- The Impact of Bank Saving and Bank Credit on Economic Growth in Ethiopia: An ARDL Co-integration Approach
- The Predictive Value of Serological Markers in Diagnosis of Celiac Disease
- A Comparison between Intrathecal Dexmedetomidine and Fentanyl as an Adjuvant to Hyperbaric Bupivacaine in Spinal Anaesthesia for Lower Limb Surgeries - A Double Blind Controlled Study
- A Study of Prolactin as a Diabetogenic Factor in Type I&Type II Diabetic Patients
Last modified: 2021-06-30 17:48:27